Results 21 to 30 of about 147,677 (311)

Cannabis sativa [PDF]

open access: yesCurrent Biology, 2020
Schilling et al. introduce and discuss Cannabis.
Susanne, Schilling   +2 more
openaire   +2 more sources

Medicinal Cannabis for the Treatment of Chronic Refractory Pain: An Investigation of the Adverse Event Profile and Health-Related Quality of Life Impact of an Oral Formulation

open access: yesMedical Cannabis and Cannabinoids, 2022
Introduction: Medicinal cannabis is prescribed in Australia for patients with chronic refractory pain conditions. However, measures of safety and effectiveness of different cannabinoids are lacking.
Sarah Abelev   +5 more
doaj   +1 more source

Risk assessment of metals measured in regulated Canadian dried cannabis and cannabis vaping products: case study and perspectives

open access: yesFrontiers in Toxicology
In 2018, the Cannabis Act and its regulations established a strict legal framework for controlling production, distribution, sale and possession of cannabis across Canada.
Sathish Achuthan   +2 more
doaj   +1 more source

In-situ TD-GCMS measurements of oxidative products of monoterpenes at typical vaping temperatures: implications for inhalation exposure to vaping products

open access: yesScientific Reports, 2022
Vaping is gaining in popularity. However, there is still much that remains unknown about the potential risk and harms of vaping. Formation of oxidative products is one of such areas that are not well understood.
Jiping Zhu   +4 more
doaj   +1 more source

The Cannabis Terpenes [PDF]

open access: yesMolecules, 2020
Terpenes are the primary constituents of essential oils and are responsible for the aroma characteristics of cannabis. Together with the cannabinoids, terpenes illustrate synergic and/or entourage effect and their interactions have only been speculated in for the last few decades.
Sarana Rose Sommano   +3 more
openaire   +3 more sources

Canadians’ use of cannabis for therapeutic purposes since legalization of recreational cannabis: a cross-sectional analysis by medical authorization status

open access: yesBMC Medicine
Background There has been a precipitous decline in authorizations for medical cannabis since non-medical cannabis was legalized in Canada in 2018. This study examines the demographic and health- and medical cannabis-related factors associated with ...
Lynda G. Balneaves   +9 more
doaj   +1 more source

Hemp Cultivation and Crop Diversification: Implications for Ecosystem Services in Kentucky

open access: yesApplied Economic Perspectives and Policy, EarlyView.
ABSTRACT This study examines the ecosystem benefits of expanding hemp cultivation by assessing its impact on crop diversity. Using scenario‐based simulations and fixed‐effect panel regressions with county‐level data in Kentucky, we find that increased hemp acreage tends to enhance crop diversity, improving water quality and bird diversity.
Yunsun Park   +4 more
wiley   +1 more source

Trends in hospitalizations for cannabinoid hyperemesis syndrome in Canada, 2016–17 to 2024–25

open access: yesFrontiers in Public Health
ObjectiveTo evaluate trends in CHS hospitalizations in Canada, including their frequency and individual characteristics.MethodsThis study utilized data from the Canadian Institute for Health Information's Discharge Abstract Database to perform ...
Sieara Plebon-Huff   +2 more
doaj   +1 more source

Re-medicalizing cannabis : science, medicine and policy, 1973 to the early twenty-first century [PDF]

open access: yes
When cannabis-based medicine was withdrawn in the UK in 1973 it appeared cannabis' career as a medicine had ended, but even as cannabis became regulated solely as an illicit drug, it appeared it was being re-medicalized.
Taylor, Suzanne
core   +1 more source

Pricing Dynamics in the US Hemp Market: A Vertical Price Transmission Analysis of the Hemp Value Chain

open access: yesAgribusiness, EarlyView.
ABSTRACT The US hemp market is a new and nascent industry that has been devoid of research for about half a century. This study examined the effects of exogenous shock on price at each phase of the value chain—Farm (hemp biomass), and its impact on prices at other phases of the value chain—Intermediary Processor (crude cannabidiol hemp) and Final ...
Solomon Odiase   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy